Lived experience conversation
Meg Burgess, Specialist Nurse at Prostate Cancer UK, leads a lived experience conversation with Tony, Junior, and Patrick.
Best practice in active surveillance for men with prostate cancer: a Prostate Cancer UK consensus statement
The article presents a consensus statement on prostate cancer active surveillance best practices in the UK, highlighting practice variations and the need for improved patient information and support.
Risks, Counselling, and the importance of Active Surveillance
David Thurtle, senior urology registrar in the East of England, introduces you to the importance of Active Surveillance.
Active Surveillance – the Wild West of prostate cancer management
Vincent J Gnanapragasam, Professor of Urology in the University of Cambridge and an Honorary Consultant Urologist at Addenbrooke’s Hospital in Cambridge, presents the difficulties and challenges of Active Surveillance.
Patients’ Story
Nick Ridgman, Head of Support Services at Prostate Cancer UK, is joined by Robin Porter and Anthony Francis, patients with lived experience, to discuss missing recurrences after prostatectomy.
Active Surveillance entry criteria
Jaimin Bhatt, Consultant Urological and Robotic Surgeon at the Queen Elizabeth University Hospital in Glasgow, presents a session on Active Surveillance focusin on entry criteria.
Active Surveillance – Follow up protocol and risk stratification
Lucy Simmons, Consultant Urologist at the Royal United Hospitals in Bath, presents a session on Active Surveillance focusing on follow up protocol and risk stratification.
Active surveillance: Supported self-management and Nurse led approach
Vineetha Thankapannair, Clinical Nurse Specialist at the Cambridge University Hospitals, presents a session on Active Surveillance focusing on supported self-management and nurse led approach.
Active Surveillance Hub
The Active Surveillance Hub offers healthcare professionals evidence-based resources, guidelines, and tools to support clinical decision-making and patient care in managing prostate cancer, enhancing both practice and patient outcomes.
